Providing market intelligence for more than 35 years

In The News

Roku Is Winning The Streaming-Video Device Game

A total of 21 percent of U.S. broadband households with at least one Internet-connected CE device use a streaming-media player as their primary platform for streaming online video, up from the year-ago 12 percent, Parks said. In contrast, streaming-video usage declined for connected gaming consoles, and it increased modestly for smart TVs, the research company said. Game consoles, nonetheless, are still used more than streaming-media players to stream video, Parks said.
In the first quarter of 2015, 97.6 million households had broadband Internet access, and 65.8 percent of them, or 64 million, connected at least one CE device to the Internet. Of those 64 million households, 21 percent mostly use a streaming-media player to stream content from the Internet, Parks said.

From the article "Roku Is Winning The Streaming-Video Device Game" by Joseph Palenchar.

Previously In The News

Parks: US Churn Rate For OTT Services Is 19%

This is according to Parks Associates’ latest ‘OTT Video Market Tracker’ stats, which said that overall churn rate for OTT services has been roughly stable for the past year. At the end of 2015, 20...

One in five US subscribers now ‘dissatisfied’ with pay TV service

Some 20% of US pay TV subscribers are now dissatisfied with their pay TV service, according to research from Parks Associates. The future represents a 100% increase since 2013, according to Parks....

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...